ITM5 (AA 1-100) antibody (Biotin)
Quick Overview for ITM5 (AA 1-100) antibody (Biotin) (ABIN1700042)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1-100
-
Predicted Reactivity
- Human
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human IFITM5
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C for 12 months.
-
Expiry Date
- 12 months
-
-
- ITM5
-
Background
-
Synonyms: Bone-restricted interferon-induced transmembrane protein-like protein, BRIL, Fragilis4, Hrmp1, ITM5, M5_HUMAN, Interferon-induced transmembrane protein 5.
Background: IFITM5 is a membrane protein thought to play a role in bone mineralization. This gene is located on chromosome 11 in a cluster of related genes which are induced by interferon, however, this gene has not been shown to be interferon inducible. A similar gene, located in a gene cluster on mouse chromosome 7, is a member of the interferon-inducible fragilis gene family. The mouse gene encodes a transmembrane protein described as participating in germ cell competence. A mutation in the 5' UTR of this gene has been associated with osteogenesis imperfecta type V (PMID: 22863190, 22863195).
Target
-
